NeurOmics website

NeurOmics website

Integrated European Project on Omics Research of
Rare Neuromuscular and Neurodegenerative Diseases
Menu
  • Project welcome
    • About the project
    • Coordination
    • Innovation council
    • Patient advisory council
    • Project board
    • Project ethics council
    • Scientific advisory board
    • Close
  • News
    • News & events
      • Annual project reports
      • Newsletter
      • Draft of EU data protection regulation – Concerns raised over draft of EU data protection regulation
    • Close
  • Diseases
    • Disease overview
      • Ataxia
      • Congenital muscular dystrophy
      • Congenital myasthenic syndrome
      • Fronto-temporal lobe dementia
      • Hereditary motor neuropathies – Charcot-Marie-Tooth disease
    •  
      • Hereditary spastic paraplegias
      • Huntington’s disease
      • Muscular channelopathy
      • Muscular dystrophy
      • Spinal muscular atrophy – Lower motor neuron disease
    • Close
  • Workpackages
    • Workpackages
      • 1 – Deep phenotype analysis in pre-symptomatic and symptomatic NDD/NMD patients
      • 2 – Identification of novel disease genes in NDD/NMD patients
      • 3 – Identification of modifying factors in cohorts enriched by deep phenotyping
      • 4 – Identification of hypothesis-driven biomarkers for disease progression
      • 5 – Development and implementation of disease group overlapping NGS-based diagnostic panels
      • 6 – Diagnostic read outs for predicting disease modification
      • 7 – Omics-based biomarkers for progression and therapy monitoring related to disease pathways
    •  
      • 8 – Bioinformatic tools for diagnostic prediction
      • 9 – Omics-assisted therapy development
      • 10 – Elucidation of pathogenesis and monitoring of treatment
      • 11 – Modifier gene identification, prioritization and study
      • 12 – Impact and communication
      • 13 – Research infrastructure
      • 14 – Project Management
    • Close
  • Project partners
    • Project partners
      • Agilent Technologies
      • Ariadne Diagnostics, LLC
      • Bio-Prodict
      • Cambridge University
      • deCODE genetics
      • German Center for Neurodegenerative Diseases (DZNE)
      • Institut National de la Santé et de la Recherche Médicale
    •  
      • Leiden University Medical Center – LUMC
      • Newcastle University
      • Profilomic
      • Universitätsklinikum Freiburg
      • Universite d’Aix Marseille
      • University College London – ICH
      • University College London – IoN
    •  
      • University College London – MRC
      • University Hospital Cologne
      • University of Antwerp – CDE
      • University of Ferrara
      • University of Milan
      • University of Tübingen
      • University of Western Australia
    • Partner resources
      • Intranet
    • Close
  • Publication highlights
    • Publication highlights
      • Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study

        Alhassane Diallo, Heike Jacobi, Arron Cook, Robyn Labrum, Prof Alexandra Durr, Prof Alexis Brice, Perrine Charles, Cecilia Marelli, Caterina Mariotti, Lorenzo Nanetti, Marta Panzeri, Maria Rakowicz, Anna Sobanska, Anna Sulek, Tanja Schmitz-Hübsch, Ludger Schöls, Holger Hengel, Prof Bela Melegh, Prof Alessandro Filla, Antonella Antenora, Jon Infante, Prof José Berciano, Bart P van de Warrenburg, Dagmar Timmann, Sylvia Boesch, Prof Massimo Pandolfo, Prof Jörg B Schulz, Peter Bauer, Paola Giunti, Jun-Suk Kang, Prof Thomas Klockgether, Sophie Tezenas du Montcel


        RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases

        Hanns Lochmüller, Dorota M. Badowska, Rachel Thompson, Nine V. Knoers, Annemieke Aartsma-Rus, Ivo Gut, Libby Wood, Tina Harmuth, Andre Durudas, Holm Graessner, Franz Schaefer, Olaf Riess, RD-Connect consortium, NeurOmics consortium & EURenOmics consortium


        The Beta-Adrenergic Agonist Salbutamol Modulates Neuromuscular Junction Formation in Zebrafish Models of Human Myasthenic Syndromes

        Grace McMacken, Dan Cox, Andreas Roos, Juliane Müller, Roger Whittaker, Hanns Lochmüller


        Rare non-synonymous variants in SORT1 are associated with increased risk for frontotemporal dementia

        Stéphanie Philtjens, Sara Van Mossevelde, Julie van der Zee, Eline Wauters, Lubina Dillen, Mathieu Vandenbulcke, Rik Vandenberghe, Adrian Ivanoiu, Anne Sieben, Christiana Willems, Luisa Benussi, Roberta Ghidoni, Giuliano Binetti, Barbara Borroni, Alessandro Padovani, Pau Pastor, Monica Diez-Fairen, Miquel Aguilar, Alexandre de Mendonça, Gabriel Miltenberger-Miltényi, Isabel Hernández, Merce Boada, Agustín Ruiz, Benedetta Nacmiass, Sandro Sorbi, Maria Rosário Almeida, Isabel Santana, Jordi Clarimón, Alberto Lleó, Giovanni B. Frisoni, Raquel Sanchez-Valle, Albert Lladó, Estrella Gómez-Tortosa, Ellen Gelpi, Marleen Van den Broeck, Karin Peeters, Patrick Cras, Peter P. De Deyn, Sebastiaan Engelborghs, Marc Cruts, Christine Van


        PFN2 and GAMT as common molecular determinants of axonal Charcot-Marie-Tooth disease

        Manisha Juneja, Abdelkrim Azmi, Jonathan Baets, Andreas Roos, Matthew J Jennings, Paola Saveri, Chiara Pisciotta, Nathalie Bernard-Marissal, Bernard L Schneider, Catherine Verfaillie, Roman Chrast, Pavel Seeman, Angelika F Hahn, Peter de Jonghe, Stuart Maudsley, Rita Horvath, Davide Pareyson, Vincent Timmerman


        Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy

        Pietro Spitali, Kristina Hettne, Roula Tsonaka, Ekrem Sabir, Alexandre Seyer, Jesse B.A. Hemerik, Jelle J. Goeman, Esther Picillo, Manuela Ergoli, Luisa Politano, Annemieke Aartsma-Rus


        Harmonising phenomics information for a better interoperability in the rare disease field

        Sylvie Maiellaa, Annie Olrya, Marc Hanauera, Valérie Lanneaua, Halima Lourghia, Bruno Donadillea, Charlotte Rodwella, Sebastian Köhlerc, Dominik Seelowc, Simon Juppe, Helen Parkinsone, Tudor Grozaf, Michael Brudnod, Peter N. Robinsonb, Ana Ratha


        A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome

        Eduardo de Paula Estephan, Cláudia Ferreira da Rosa Sobreira, André Clériston José dos Santos, Pedro José Tomaselli, Wilson MarquesJr., Roberta Paiva Magalhães Ortega, Marcela Câmara Machado Costa, André Macedo Serafim da Silva, Rodrigo Holanda Mendonça, Vitor Marques Caldas, Antonio Alberto Zambon, Osório Abath Neto, Paulo Eurípedes Marchiori, Carlos Otto Heise, Umbertina Conti Reed, Yoshiteru Azuma, Ana Töpf, Hanns Lochmüller, Edmar Zanoteli


        ALS-related human cortical and motor neurons survival is differentially affected by Sema3A

        Anastasya Birger, Miri Ottolenghi, Liat Perez, Benjamin Reubinoff & Oded Behar


        Natural History, Trial Readiness and Gene Discovery: Advances in Patient Registries for Neuromuscular Disease

        Rachel Thompson, Agata Robertson, Hanns Lochmüller


    • Close
  • Resources
    • Close
    • Contact us

      Please use the form below to get in
      touch and we will try to answer
      your question.

      Please note that this is a research
      project and as such we are unable
      to answer questions about individual
      conditions or people.

      Please wait...
    • Close

Universitätsklinikum Freiburg

Division of Neuropediatrics and Muscle Disorders

The University of Freiburg Medical Centre (UKL-FR) is one of the largest medical centres in Germany. The Medical School is one of the most prestigious research-driven medical schools in Germany. UKL-FR has approximately over 300,000 patients annually. 8,240 employees, 1,071 doctors and 1,972 paramedic personnel.

In 2001 the Division of Neuropaediatrics and Muscle Disorders together with the Clinical Trials Centre of the UKL-FR established a clinical trial coordination centre for neuromuscular disorders (CTCC) within the German network for Muscular Dystrophies MD-NET – www.md-net.org and have coordinated since then various clinical trials. Since 2007 this infrastructure has been extended to a European level and integrated into the EU funded Network of Excellence for rare inherited neuromuscular disorders, TREAT-NMD – www.treat-nmd.eu.

Role within Neuromics

The existing TREAT-NMD Care and Trial Site Registry (CTSR) will be further developed to ensure it is collecting all requisite data for Omics purposes, and bring in additional NMD sites and integrate NDD sites.

Related projects

 

  • CARE-NMD
  • TREAT-NMD

 

Workpackage involvement

  • Workpackage 13 - Research infrastructure

Partner details

Mathildenstrasse 1
Freiburg
Germany
+49-(0)761-27043750
www.uniklinik-freiburg.de

Contacts


Jan Kirschner

Kirsten König

RDConnect_footer-160x26

IRDiRC Logo

 
     

The NeurOmics project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 2012-305121.

 
   

Copyright © 2018 · Dynamik Website Builder On Genesis Framework · WordPress · Log in

/* ----------------------------------------- */ /* Content Template: OrganizationSinglePage - start */ /* ----------------------------------------- */ /* ----------------------------------------- */ /* Content Template: OrganizationSinglePage - end */ /* ----------------------------------------- */ /* ----------------------------------------- */ /* Content Template: List of contacts side - start */ /* ----------------------------------------- */ /* ----------------------------------------- */ /* Content Template: List of contacts side - end */ /* ----------------------------------------- */
This site uses cookies - Find out more -